P1093: A Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK 1349572, a novel integrase inhibitor, in combination regimens in HIV-1 Infected Infants, Children and Adolescents

Project: Research project

Project Details

StatusFinished
Effective start/end date12/31/17 → 12/30/19

Funding

  • Johns Hopkins University
  • GlaxoSmithKline LLC